Literature DB >> 20397256

Role of monocytes and macrophages in experimental and human acute liver failure.

Lucia A Possamai, Charalambos Gustav Antoniades, Quentin M Anstee, Alberto Quaglia, Diego Vergani, Mark Thursz, Julia Wendon.   

Abstract

Acute liver failure (ALF) is a devastating clinical syndrome characterised by progressive encephalopathy, coagulopathy, and circulatory dysfunction, which commonly leads to multiorgan failure and death. Central to the pathogenesis of ALF is activation of the immune system with mobilisation of cellular effectors and massive production of cytokines. As key components of the innate immune system, monocytes and macrophages are postulated to play a central role in the initiation, progression and resolution of ALF. ALF in humans follows a rapidly progressive clinical course that poses inherent difficulties in delineating the role of these pivotal immune cells. Therefore, a number of experimental models have been used to study the pathogenesis of ALF. Here we consider the evidence from experimental and human studies of ALF on the role of monocytes and macrophages in acute hepatic injury and the ensuing extrahepatic manifestations, including functional monocyte deactivation and multiple organ failure.

Entities:  

Keywords:  Acute liver failure; Cytokine; Inflammation; Macrophage; Monocyte; Monocyte chemoattractant protein-1/chemokine (C-C motif) receptor-2

Mesh:

Substances:

Year:  2010        PMID: 20397256      PMCID: PMC2856819          DOI: 10.3748/wjg.v16.i15.1811

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  66 in total

1.  Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.

Authors:  Charalambos Gustav Antoniades; Philip A Berry; Edward T Davies; Munther Hussain; William Bernal; Diego Vergani; Julia Wendon
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

2.  Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity.

Authors:  Donna M Dambach; Stephen K Durham; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2005-08-02       Impact factor: 4.219

3.  Cytokines and toxicity in acetaminophen overdose.

Authors:  Laura P James; Pippa M Simpson; Henry C Farrar; Gregory L Kearns; Gary S Wasserman; Jeffrey L Blumer; Michael D Reed; Janice E Sullivan; Jack A Hinson
Journal:  J Clin Pharmacol       Date:  2005-10       Impact factor: 3.126

4.  Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species.

Authors:  S L Michael; N R Pumford; P R Mayeux; M R Niesman; J A Hinson
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

5.  Patients with acute on chronic liver failure display "sepsis-like" immune paralysis.

Authors:  Hermann E Wasmuth; Dagmar Kunz; Eray Yagmur; Annette Timmer-Stranghöner; Daniel Vidacek; Elmar Siewert; Jens Bach; Andreas Geier; Edmund A Purucker; Axel M Gressner; Siegfried Matern; Frank Lammert
Journal:  J Hepatol       Date:  2005-02       Impact factor: 25.083

6.  Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille Calmette-Guerin and lipopolysaccharide.

Authors:  S Kobayashi; J Nishihira; S Watanabe; S Todo
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.

Authors:  Atsushi Hiraoka; Norio Horiike; Sk Md Fazle Akbar; Kojiro Michitaka; Takami Matsuyama; Morikazu Onji
Journal:  J Gastroenterol       Date:  2005-01       Impact factor: 7.527

8.  Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice.

Authors:  H Louis; J L Van Laethem; W Wu; E Quertinmont; C Degraef; K Van den Berg; A Demols; M Goldman; O Le Moine; A Geerts; J Devière
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

9.  Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis.

Authors:  S C Afford; N C Fisher; D A Neil; J Fear; P Brun; S G Hubscher; D H Adams
Journal:  J Pathol       Date:  1998-09       Impact factor: 7.996

10.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

View more
  21 in total

1.  Modulation of AP-endonuclease1 levels associated with hepatic cirrhosis in rat model treated with human umbilical cord blood mononuclear stem cells.

Authors:  Ahmad R Bassiouny; Amira Z Zaky; Shaymaa A Abdulmalek; Kamal M Kandeel; Alaa Ismail; Marie Moftah
Journal:  Int J Clin Exp Pathol       Date:  2011-10-16

Review 2.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 3.  The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM).

Authors:  Tatyana N Tarasenko; Peter J McGuire
Journal:  Mol Genet Metab       Date:  2017-06-24       Impact factor: 4.797

4.  Opposing effects of prednisolone treatment on T/NKT cell- and hepatotoxin-mediated hepatitis in mice.

Authors:  Hyo-Jung Kwon; Young-Suk Won; Ogyi Park; Dechun Feng; Bin Gao
Journal:  Hepatology       Date:  2014-01-21       Impact factor: 17.425

5.  Acute organ failure following the loss of anti-apoptotic cellular FLICE-inhibitory protein involves activation of innate immune receptors.

Authors:  N Gehrke; D Garcia-Bardon; A Mann; A Schad; Y Alt; M A Wörns; M F Sprinzl; T Zimmermann; J Menke; A J Engstler; I Bergheim; Y-W He; P R Galle; M Schuchmann; J M Schattenberg
Journal:  Cell Death Differ       Date:  2014-10-24       Impact factor: 15.828

6.  MRI of magnetically labeled mesenchymal stem cells in hepatic failure model.

Authors:  Kyu Ri Son; Se Young Chung; Hyo-Cheol Kim; Hoe Suk Kim; Seung Hong Choi; Jeong Min Lee; Woo Kyung Moon
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

7.  Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism.

Authors:  Tatyana N Tarasenko; Maxim Jestin; Shingo Matsumoto; Keita Saito; Sean Hwang; Oksana Gavrilova; Niraj Trivedi; Patricia M Zerfas; Emanuele Barca; Salvatore DiMauro; Julien Senac; Charles P Venditti; Murali Cherukuri; Peter J McGuire
Journal:  J Mol Med (Berl)       Date:  2019-05-03       Impact factor: 4.599

8.  Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.

Authors:  Catherine Ingels; Holger J Møller; Troels K Hansen; Pieter J Wouters; Ilse Vanhorebeek; Greet Van den Berghe
Journal:  J Clin Immunol       Date:  2012-11-13       Impact factor: 8.317

Review 9.  Role of inflammation and infection in the pathogenesis of human acute liver failure: Clinical implications for monitoring and therapy.

Authors:  Mhairi C Donnelly; Peter C Hayes; Kenneth J Simpson
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

10.  Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice.

Authors:  Hsein-San Hou; Ching-Len Liao; Huey-Kang Sytwu; Nan-Shih Liao; Tien-Yu Huang; Tsai-Yuan Hsieh; Heng-Cheng Chu
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.